Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy

Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy
复制标题

DOI:
10.1159/000507585
复制
发表时间:
2020-09-01
期刊:
影响因子:
3.5
通讯作者:
Takeishi, Yasuchika
Takeishi, Yasuchika
中科院分区:
医学3区
文献类型:
--
作者:
Oikawa, Masayoshi;Yoshihisa, Akiomi;Takeishi, Yasuchika

文献摘要

被引文献

相似文献

背景:蒽环类抗生素被用于治疗各种类型的癌症,然而,心脏毒性会对患者预后产生负面影响。目的:本研究的目的是调查一系列的变化,在与蒽环类抗生素治疗患者的心肌肌钙蛋白I(TnI)和B型利钠肽(BNP)。方法:91例连续癌症患者计划蒽环类抗生素治疗,并随访12个月。结果:根据随访期间的TnI水平,将患者分为两组:TnI升高组(TnI ≥ 0.03 ng/mL;n= 37)和TnI正常组(n= 54)。在TnI升高组中,TnI水平在3和6个月时升高,但在蒽环类药物给药后12个月时恢复到正常范围内。与TnI不同,BNP水平在6个月后开始升高,并在12个月时保持升高。与TnI正常组相比,TnI升高组中癌症治疗相关心功能障碍的发生率更高。当我们将TnI的临界值设定为0.029 ng/mL时,预测BNP水平升高超过100 pg/mL的灵敏度和特异性分别为90%和63%。多因素Logistic回归分析显示,TnI升高是BNP升高的独立预测因子。结论:TnI升高是BNP升高的独立预测因子。在管理含蒽环类药物治疗的患者时,应考虑TnI和BNP的不同特征。
Background:Anthracycline is used to treat various types of cancer; however, cardiotoxicity negatively affects patient prognosis.Objectives:The aim of the present study was to investigate serial changes in levels of cardiac troponin I (TnI) and B-type natriuretic peptide (BNP) in patients treated with anthracycline-containing therapy.Methods:91 consecutive cancer patients planned for anthracycline treatment were enrolled and followed up for 12 months. All patients underwent echocardiography and blood sampling at baseline, 3, 6, and 12 months.Results:The patients were divided into two groups based on their TnI level during the follow-up period: the elevated TnI group (TnI >= 0.03 ng/mL;n= 37) and the normal TnI group (n= 54). In the elevated TnI group, the TnI levels increased at 3 and 6 months, but they returned to within normal range at 12 months after anthracycline administration. Unlike TnI, the BNP levels began to increase after 6 months, and remained increased at 12 months. The occurrence of cancer therapeutics-related cardiac dysfunction was higher in the elevated TnI group than in the normal TnI group. When we set the cut-off value of TnI at 0.029 ng/mL, sensitivity and specificity to predict an elevated BNP level of more than 100 pg/mL were 90 and 63%, respectively. Multivariate logistic regression analysis revealed that elevated TnI was an independent predictor of elevated BNP levels.Conclusion:Elevated TnI was an independent predictor for the development of BNP increase. The different characteristics of TnI and BNP should be considered when managing patients treated with anthracycline-containing therapy.